U.S. markets close in 3 hours 15 minutes
  • S&P 500

    3,382.41
    -82.98 (-2.39%)
     
  • Dow 30

    27,498.37
    -837.20 (-2.95%)
     
  • Nasdaq

    11,308.67
    -239.62 (-2.07%)
     
  • Russell 2000

    1,601.64
    -38.86 (-2.37%)
     
  • Crude Oil

    38.55
    -1.30 (-3.26%)
     
  • Gold

    1,907.00
    +1.80 (+0.09%)
     
  • Silver

    24.50
    -0.18 (-0.73%)
     
  • EUR/USD

    1.1823
    -0.0045 (-0.38%)
     
  • 10-Yr Bond

    0.8030
    -0.0380 (-4.52%)
     
  • GBP/USD

    1.3018
    -0.0020 (-0.16%)
     
  • USD/JPY

    104.8690
    +0.1790 (+0.17%)
     
  • BTC-USD

    12,877.05
    -272.97 (-2.08%)
     
  • CMC Crypto 200

    256.75
    -6.66 (-2.53%)
     
  • FTSE 100

    5,791.00
    -69.28 (-1.18%)
     
  • Nikkei 225

    23,494.34
    -22.25 (-0.09%)
     

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of GoHealth, Inc. (GOCO) Investors

·3 mins read

Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased GoHealth, Inc. ("GoHealth" or the "Company") (NASDAQ: GOCO) Class A common stock pursuant and/or traceable to the Company’s July 2020 initial public offering (the "IPO" or "Offering"). GoHealth investors have until November 20, 2020 to file a lead plaintiff motion.

If you suffered a loss on your GoHealth investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/gohealth-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

In July 2020, GoHealth sold approximately 43.5 million shares of stock in its initial public stock offering (the "IPO"), at $21.00 per share raising almost $914 million in new capital.

Then, on August 19, 2020, in its first quarterly earnings report following the IPO, GoHealth announced that it incurred a net loss of $22.9 million after posting net income of $15.3 million in the prior-year period.

On this news, the Company's stock price fell $1.99 per share, or 10%, to close at $17.03 per share on August 20, 2020, thereby injuring investors.

On September 15, 2020, GoHealth’s stock price closed at $12.53, a 40% decline from its IPO price.

The complaint alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that at the time of the IPO: (1) the Medicare insurance industry was undergoing a period of elevated churn, which had begun in the first half of 2020; (2) GoHealth suffered from a higher risk of customer churn due to its unique business model and limited carrier base; (3) GoHealth suffered from degradations in customer persistency and retention as a result of elevated industry churn, vulnerabilities that arose from the Company's concentrated carrier business model, and its efforts to expand into new geographies, develop new carrier partnerships and worsening product mix; (4) GoHealth had entered into materially less favorable revenue sharing arrangements with its external sales agents; and (5) these adverse financial and operational trends were internally projected by GoHealth to continue and worsen following the IPO.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased GoHealth Class A common stock, you may move the Court no later than November 20, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005204/en/

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com
shareholders@glancylaw.com